I'm surprised that we have not launched a phase III yet. We have tons of patient data from phase II. I can understand us not going into phase three if we only had data from two dozen patients from an open label study. We have shown that hundreds of patients are living longer in remission. I'm sure that a phase III announcement will come once FDA realizes it will be immoral not to approve our shock treatment.
Market Data 
Markets 
AI
